Skip to main content
Category

News Archive

Antidote-Therapeutics-logo

Antidote Therapeutics teams up with National Cancer Institute, seeks funding for nicotine-blocking drug candidate – Washington Business Journal

By News Archive

Antidote-Therapeutics-logo

Matt Kalnik wants to make smoking less addictive.

His clinical-stage company, Gaithersburg-based Antidote Therapeutics Inc., is developing a drug that would diminish the effects of nicotine in the body — to both treat diseases worsened by nicotine and help smokers quit. The businesses is looking to raise between $5 million and $10 million to run over the next two years and get its lead candidate to clinical trials.

Read More
university-system-of-maryland-usm-2-logo

Maryland Momentum Fund accepting applications | Office of Technology Commercialization

By News Archive

university-system-of-maryland-usm-2-logo

The Maryland Momentum Fund is a newly-created mechanism for investing in promising early stage companies associated with the University System of Maryland (USM). Maryland-based companies that are seeking equity financing or debt financing  that is convertible into equity may apply.  The funding provided by the Fund will normally be in the range of $150K-$250K, with a ceiling of $500K.  Recipients of this funding must obtain a matching investment (1:1) within six months, in either direction, from the date of commitment by the Fund.

Read More
blueberries-pixa

Why Food Could Be the Best Medicine of All – Time

By News Archive

blueberries-pixa

When Tom Shicowich’s toe started feeling numb in 2010, he brushed it off as a temporary ache. At the time, he didn’t have health insurance, so he put off going to the doctor. The toe became infected, and he got so sick that he stayed in bed for two days with what he assumed was the flu. When he finally saw a doctor, the physician immediately sent Shicowich to the emergency room. Several days later, surgeons amputated his toe, and he ended up spending a month in the hospital to recover.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.